Sarah Holstein, MD, PhD | Authors

Articles

Lenalidomide vs. Placebo for Multiple Myeloma Patients Following a Single ASCT

August 13, 2015

Sarah Holstein, MD, PhD, assistant professor of oncology, Roswell Park Cancer Institute, discusses a randomized study that compared lenalidomide with placebo for patients with multiple myeloma, following a single autologous stem cell transplant (ASCT).